The Dietary Supplementation of Nordihydroguaiaretic Acid (NDGA) Delayed the Loss of Climbing Ability in Drosophila Model of Parkinson's Disease

REFERENCES

• Abbott RA, Cox M, Markus H, Temkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr. 1992;46:879–884.
   PubMed Web of Science ®Google Scholar
• Amer DA, Irvine GB, El-Agnaf OM. Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders. Exp Brain Res. 2006;173:223–233.
   PubMed Web of Science ®Google Scholar
• Avanesian A, Semmani S, Jafri M. Can Drosophila melanogaster represent a model system the detection of reproductive adverse drug reactions?? Drug Dis Today. 2009;14:761–766.
   PubMed Web of Science ®Google Scholar
• Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817–827.
   PubMed Web of Science ®Google Scholar
• Benford DJ, Hanley AB, Bottrill K, Oehlschlager S, Balls M, Branca F, Castengnaro JJ, Descotes J, Hemminiki K, Lindsay D, Schitter B. Biomarkers as predictive tools in toxicity testing. The report and recommendations of EVCAM Workshop. Alt Lab Anim 2000;28:119–131.
   Web of Science ®Google Scholar
• Butterfield DA, Kanski J. Brain protein oxidation in age related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev. 2001;15:1945–1962.
   Google Scholar
• Caruana M, Hogen T, Levin J, Hillmer A, Giese A, Vassallo N. Inhibition and disaggregation of alpha Synuclein oligomers by natural polyphenolic compounds. FEBS Lett 2011;585:1113–1120.
   PubMed Web of Science ®Google Scholar
• Conway KA, Harper JD, Lansbury AT. Accelerated in vitro fibril formation by a mutant alpha synuclein linked to early onset Parkinson Disease. Nat Med. 1998;4:1318–1320.
   PubMed Web of Science ®Google Scholar
• Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889–909.
   PubMed Web of Science ®Google Scholar
• Duffy JB. GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis 2002;32:1–15.
   PubMedGoogle Scholar
• Fahn S. The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high dosage antioxidants in an attempt to slow the progression of the illness. Ann NY Acad Sci. 1989;570:186–196.
   PubMedGoogle Scholar
• Feany MB, Bender WW. A drosophila model of parkinson's disease. Nature 2000;404:394–398.
   PubMed Web of Science ®Google Scholar
• Festing MFW, Baumans V, Combes DR, Halder M, Hendricsen FM, Howard BR, Lovell DP, Moore GJ, Overend P, Wilson MS. Reducing the use of laboratory animals in biomedical research: problems and possible solutions. Alt Lab Anim 1998;26:283–301.
   PubMed Web of Science ®Google Scholar
• Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med. 2002;32:1264–1275.
   PubMed Web of Science ®Google Scholar
• Giasson BI, Ury UK, Trojanowski JQ, Lee MYE. Mutant and wild type human alpha synuclein assemble into elongated filaments with distinct morphologies in vitro. J. Biol Chem. 1999;274:7619–7622.
   PubMed Web of Science ®Google Scholar
• Goodman Y, Steiner MR, Steiner SM, Mattson MP. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta- peptide toxicity and attenuates free radicals and calcium accumulation. Brain Res. 1994;654:171–176.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Meyers RO, Timmermann BN, Dorr RT. Pharmacokinetic analysis by high performance liquid chromatography of intervenous nordihydroguaiaretic acid in the mouse. J Chromatogr B Biomed Sci App. 2001;754:85–90.
   PubMedGoogle Scholar
• Lü JM, Nurko J, Weakley SM, Jiang J, Kouglas P, Lin PH, Yao Q, Chen C. Molecular mechanisms and clinical application of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010;16: RA 93–R 100.
   Google Scholar
• Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in alpha Synuclein mice: implication for neurogenerative disorders. Science 2000;287:1265–1269.
   PubMed Web of Science ®Google Scholar
• Naoi M, Maruyama W. Future of neuroprotection in Parkinson's disease. Parkinson Relat Disord 2001;8:139–145.
   PubMed Web of Science ®Google Scholar
• Noor R, Mittal S, Iqbal J. Superoxide dismutase: applications and relevance to human diseases. Med Sci Monit 2002;8: R A 210–5.
   PubMedGoogle Scholar
• Ono K, Hasegaua K, Yoshiike Y, Takashima A, Yamada M, Naiki H. Nordihydroguaiaretic acid potentially breaks down preformed Alzheimer's beta amyloid fibrils in vitro. J Neurochem. 2002;81:434–440.
   PubMedGoogle Scholar
• Ono K, Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril- destabilizing effects for alpha synuclein fibrils in vitro. J Neurochem 2006;97:105–115.
   PubMed Web of Science ®Google Scholar
• Pal R, Miranda M, Narayan M. Nitrosative stress-induced Parkinsonian lewy like aggregates prevented through polyphenolic phytochemical analog intervention. Biochem Biophys Res Commun 2011;404:324–329.
   PubMed Web of Science ®Google Scholar
• Pendleton RG, Parvez F, Sayed M, Hillman R. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Therap. 2002;300:91–96.
   PubMed Web of Science ®Google Scholar
• Prasad KN, Cole WC, Kumar B. Multiple antioxidants in the prevention and treatment of Parkinson's Disease. J Am Coll Nutr. 1999;18:413–423.
   PubMed Web of Science ®Google Scholar
• Richie JP, Mills BJ, Lang CA. Dietary nordihydroguaiaretic acid increases the life span of the mosquitoes. Pro Soc Exp Biol Med. 1986;183:81–85.
   PubMedGoogle Scholar
• Scherzer CR, Jensen RV, Gullans SR, Feany MB. Gene expression changes presage neurodegeneration in a Drosophila model of Perkinson's disease. Hum Mol Genet. 2003;12:2457– 2466.
   PubMedGoogle Scholar
• Shishido Y, Furushiro M, Hashimoto S, Yokokura T. Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacol Biochem Behav. 2001;69:469–474.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Ara G, Beg T, Afzal M, Faisal M. Protective role of Plumbago zeylanica extract against toxic effects of ethinylestradiol in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ)Bg9 and cultured human peripheral blood lymphocytes. Alt Med Studies. 2011;1e7:26–29.
   Google Scholar
• Siddique YH, Ara G, Beg T, Afzal M. Protective role of nordihydroguaiaretic acid (NDGA) against the genotoxic damage induced by ethynodiol diacetate in human lymphocytes in vitro. J Environ Biol 2007;28:279–282.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Beg T, Afzal M. Protective effect of nordihydroguaiaretic acid (NDGA) against norgestrel induced genotoxic damage. Toxicol in vitro. 2006;20:227–233.
   PubMed Web of Science ®Google Scholar
• Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism and cellular and molecular mechanisms. J Agric Food Chem. 2008;56:4855–4873.
   PubMed Web of Science ®Google Scholar
• Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83–106.
   PubMed Web of Science ®Google Scholar
• Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Harrison DE. Nordihydroguaiaretic acid and aspirin increase life- span of genetically heterogeneous mice. Aging Cell. 2008;7:641– 650.
   PubMed Web of Science ®Google Scholar
• Van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G. Neuropathology in mice expressing human alpha-synuclein. J Neurosci. 2000;15:6021–9.
   Google Scholar
• Xun Z, Kaufman TC, Clemmer DE. Proteome response to the panneural expression of human wild type alpha synuclein: a drosophila model of Parkinson's Disease. J Proteome Res 2008;7 3911–3921.
   PubMed Web of Science ®Google Scholar
• Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abott NJ. Flavonoid permeability across an insitu model of the blood brain barrier. Free Radic Biol. Med. 2004;36:592–604.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis. 2000;7:240–250.
   PubMed Web of Science ®Google Scholar